Literature DB >> 34103038

Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.

Tang-Hsiu Huang^1,2, Chin-Wei Kuo^1,2, Chian-Wei Chen¹, Yau-Lin Tseng³, Chao-Liang Wu⁴, Sheng-Hsiang Lin^5,6,7.

Abstract

Entities: Chemical Disease Gene Species

Year: 2021 PMID： 34103038 PMCID： PMC8186065 DOI： 10.1186/s12890-021-01559-7

Source DB: PubMed Journal: BMC Pulm Med ISSN： 1471-2466 Impact factor: 3.317

× No keyword cloud information.

Correction to: BMC Pulm Med (2021) 21:165 https://doi.org/10.1186/s12890-021-01530-6

Following publication of the original article [1], it was brought to our attention that panel ‘e’ was missing from Fig. 2; the figure has since been corrected in the published article.

1 in total

1. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.

Authors: Tang-Hsiu Huang; Chin-Wei Kuo; Chian-Wei Chen; Yau-Lin Tseng; Chao-Liang Wu; Sheng-Hsiang Lin
Journal: BMC Pulm Med Date: 2021-05-15 Impact factor: 3.317

1 in total